Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease Marie FiskParag R. GajendragadkarJoseph Cheriyan Leading Article 07 February 2014 Pages: 155 - 165
Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence Csaba András Dézsi Review Article Open access 03 January 2014 Pages: 167 - 173
New Oral Anticoagulants in Practice: Pharmacological and Practical Considerations Yishen WangBeata Bajorek Review Article 23 January 2014 Pages: 175 - 189
Meta-Analysis of the Cardiovascular Outcomes with Dipeptidyl Peptidase 4 Inhibitors: Validation of the Current FDA Mandate Shikhar AgarwalAkhil ParasharVenu Menon Systematic Review 01 April 2014 Pages: 191 - 207
Cost Effectiveness of Eplerenone in Patients with Chronic Heart Failure Zanfina AdemiKumar PasupathiDanny Liew Original Research Article 08 March 2014 Pages: 209 - 216
Effect of Esomeprazole With/Without Acetylsalicylic Acid, Omeprazole and Lansoprazole on Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers Tommy AnderssonPeter NagyLars Wallentin Original Research Article 28 March 2014 Pages: 217 - 227
Heart Rate Reduction with Ivabradine in Patients with Acute Decompensated Systolic Heart Failure Luis SargentoMilan SatendraRoberto Palma dos Reis Short Communication 23 January 2014 Pages: 229 - 235
Erratum to: Comparison of the Phase III Clinical Trial Designs of Novel Oral Anticoagulants Versus Warfarin for the Treatment of Nonvalvular Atrial Fibrillation: Implications for Clinical Practice Carlos J. Gonzalez-QuesadaRobert P. Giugliano Erratum 29 April 2014 Pages: 237 - 237
Erratum to: Antihypertensive Efficacy of Triple Combination Perindopril/Indapamide Plus Amlodipine in High-Risk Hypertensives: Results of the PIANIST Study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients) Kálmán Tóthon behalf of PIANIST Investigators Erratum 11 April 2014 Pages: 239 - 239
